SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as record Super Bowl betting drives immense volume and its Crypto.com partnership expands prediction markets, while the community actively debates whether emerging unregulated prediction platforms pose a significant threat ahead of next week's anticipated earnings.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending following its decision to pull a newly launched compounded weight-loss pill due to regulatory pressure and legal threats. This move has sparked debate, with some viewing it as a significant setback while others believe it strategically removes a legal overhang and positions the core telehealth platform for a rebound, amplified by its Super Bowl ad.

JERRY (JYAI) is a Matt Furie's artistic style; it features an AI-powered content creation hub that produces community-driven video series and art.  Jerry the Turtle, created by Matt Furie, is a character inspired by Furie’s artistic style. JERRY is also an AI-driven meme coin with an ambitious vision. The goal is to establish an AI-powered production house dedicated to creating a video series or episodes featuring characters from Matt Furie’s universe alongside those from Jerry’s world.  This unique blend of characters aims to produce the ultimate crypto-based series. Additionally, we are developing an app that will offer an exclusive, ad-free video series featuring characters from both Matt Furie’s creations and the Jerry Universe. Users will be able to download and share videos directly through the platform.  But that’s not all! A special Jerry Art Panel will showcase original Jerry characters, artwork, and fan creations—free to explore, download, and share with the community.

Jerry The Turtle By Matt Furie

JYAI CRYPTO is trending as community anticipation builds around its confirmed Tier 1 exchange listings and recent debut on platforms like KuCoin Alpha and Bitget. Enthusiasts are actively comparing it to early successful memecoins, fueled by its aggressive 12-week marketing initiative and developer updates.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending following a significant Super Bowl commercial featuring Christina Applegate for its Briumvi multiple sclerosis drug, which the community views as a powerful boost for brand visibility and patient confidence. This marketing success, combined with growing discussion over a competitor's drug (Fenebrutinib) and its potential liver toxicity concerns, is intensifying conversation around Briumvi's market leadership and long-term value.

UNI is the governance token for Uniswap, an Automated Market Marker DEX on the Ethereum blockchain. The UNI token allows token holders to participate in the governance of the protocol. Key decisions such as usage of the treasury or future upgrades can be decided through a governance vote.

UniSwap

Uniswap (UNI) is trending as its community overwhelmingly supports a game-changing governance proposal to activate a fee switch and implement a significant token burn, aiming to align the protocol's high fee generation with UNI's value and establish deflationary tokenomics.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is a focal point of discussion as investors eagerly anticipate a potential strategic partnership with POSCO and factor in the positive impact of an expiring slab contract and rising hot-rolled coil prices, leading to strong community speculation about a significant short squeeze and long-term value despite recent equity dilution.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The biotech sector is seeing significant M&A interest following the J.P. Morgan Healthcare Conference, with recent acquisitions and big pharma patent cliffs driving community sentiment that the XBI is undervalued and poised for further gains. This optimism is balanced by some concerns about market overextension, though innovation in drug discovery and increasing regulatory flexibility provide a supportive backdrop.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is actively trending ahead of its Q4 earnings report on February 9, with community speculation about a potential leak and high expectations for a strong beat and optimistic 2026 guidance, driven by its AI-powered credit platform and recent substantial ABS and forward flow agreements. Despite these strong fundamentals and expanding partnerships, the stock remains a hotly debated topic, with many viewing it as significantly undervalued while others express frustration over persistent market volatility and broader fintech sector pressures.

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using a Precision Timed Release drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focused on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in May 2012 and is headquartered in Kansas City, KS.

Cingulate Inc

Cingulate Inc. is garnering significant attention following FDA acceptance of its NDA for CTx-1301, a potentially game-changing ADHD treatment, as the community eagerly awaits impending US patent news, fueling speculation of substantial market revaluation due to its low float.

Investment Managers Series Trust II - Tradr 2X Long APLD Daily ETF

Tradr 2X Long APLD Daily ETF

APLX is trending due to significant magnified gains from the underlying APLD's strong performance in the AI and data center sectors, with the community actively discussing its "parabolic" moves and potential for quick profits, while also acknowledging the amplified volatility and risks inherent in this 2x leveraged ETF.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BNY Mellon High Yield Strategies Fund Sub-Adviser Name Change

The sub-adviser of BNY Mellon High Yield Strategies Fund (NYSE: DHF), Alcentra NY, LLC, has changed its name to BSP NY LLC. Accordingly, effective immediately, all references to Alcentra NY, LLC and...

BNY Mellon High Yield Strategies Fund Declares Dividend

On January 22, 2026, the Board of Trustees of BNY Mellon High Yield Strategies Fund (NYSE: DHF) declared from net investment income a monthly cash dividend of $0.0175 per share of beneficial...

BNY Mellon High Yield Strategies Fund is a non-diversified, closed-end management investment company. Its primary investment objective is to seek high current income. The firm invests its assets in income securities of U.S. issuers rated below investment grade quality or unrated income securities that The Dreyfus Corp., serving as the fund's investment manager and administrator. The company was founded on March 16, 1998 and is headquartered in New York, NY.

BNY Mellon High Yield Strategies Fund

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

DHF
BNY Mellon High Yield Strategies Fund

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest DHF News

DHFBNY Mellon High Yield Strategies Fund